Nasdaq Net Change Percentage Gainers & Losers

Dow Jones07-30
GAINERS
COMPANYSYMBOLLASTCHANGEPERCENTVOLUME
------------------------------------
NIP Group ADRNIPG16.507.4882.936,927,423
InspiratoISPO5.241.7650.575,552,289
Shyft GroupSHYF16.302.5118.20812,249
iClick Interactive ADRICLK2.720.2912.1187,664
ON SemiconductorON78.278.1011.5422,276,356
GrShr 2x Long TSLA DlyTSLR17.931.7911.09898,687
Direxion TSLA Bull 2XTSLL11.851.1811.0651,945,071
T-Rex 2X Lg Tesla DlyTSLT16.211.5910.8810,536,854
Corvus PharmaceuticalsCRVS2.860.2810.85438,096
Focus Impact BH3 ABHAC11.761.069.91151,563
LOSERS
COMPANYSYMBOLLASTCHANGEPERCENTVOLUME
------------------------------------
Cognition TherapeuticsCGTX1.33-1.04-43.8826,237,608
Ventyx BiosciencesVTYX2.28-0.67-22.714,121,438
Integra LifeSciencesIART25.42-6.01-19.126,075,867
SilicomSILC13.59-2.51-15.59178,377
Pharming Group ADRPHAR6.82-1.17-14.649,407
PersonalisPSNL3.01-0.45-12.90984,334
Eagle PharmaceuticalsEGRX5.05-0.67-11.71143,024
Generation BioGBIO3.11-0.40-11.4075,966
T-Rex 2X Invr Tesla DlyTSLZ15.20-1.89-11.069,529,494
Tradr 2X Sh TSLA DailyTSLQ27.06-3.36-11.057,574,952
Only includes stocks with a prior day close of $2 a share
or higher and at least 2,000 shares traded today.
Data are delayed at least 15 minutes.
Source: WSJ Market Data Group

(END) Dow Jones Newswires

July 29, 2024 17:38 ET (21:38 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment